CVRx Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
CVRx Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
CVRx股票：分析師觀點的深入分析（5個評級）
A comprehensive examination of how financial experts perceive...In the last three months, 5 analysts have published ratings on CVRx (NASDAQ:CVRX), offering a diverse range of perspectives from bullish to bearish.
在過去三個月中，有5位分析師就CVRx（納斯達克股票代碼CVRX）發佈了評級，提供了從看好到看淡等多樣化的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts have recently evaluated CVRx and provided 12-month price targets. The average target is $13.4, accompanied by a high estimate of $15.00 and a low estimate of $12.00. This current average has decreased by 18.29% from the previous average price target of $16.40.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A comprehensive examination of how financial experts perceive...
正面營收趨勢：審...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。